In another study, Zhou et al. demonstrated that AKI induces a systemic inflammatory response through modulation by inhibitors of the CXCL1/CXCR2 axis, thus increasing the risk of clear cell renal cell carcinoma (ccRCC) formation (12). The gene discussed is CXCR2; the disease is acute kidney injury.